NanoBio Corporation
Quick facts
Phase 3 pipeline
- NB-001 (0.3%)
NB-001 is a nanoemulsion formulation designed to deliver antimicrobial or antiviral agents topically with enhanced penetration and bioavailability. - Vehicle versus NB-001 · Infectious Diseases
NB-001 is a vaccine.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about NanoBio Corporation
What is NanoBio Corporation's pipeline?
NanoBio Corporation has 2 drugs in Phase 3, 1 in Phase 2, 2 in Phase 1. Late-stage candidates include NB-001 (0.3%), Vehicle versus NB-001.
Related
- Sector hub: All tracked pharma companies